Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by B.L. Mitchell, Inc. The ANADA provides for the use of formalin in a water bath for the control of certain external parasites on finfish and shrimp and for the control of certain fungi on finfish eggs.
This rule is effective August 13, 2007.Start Further Info
FOR FURTHER INFORMATION CONTACT:
John K. Harshman, Center for Veterinary Medicine (HFV-104), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0169, e-mail: firstname.lastname@example.org.End Further Info End Preamble Start Supplemental Information
B.L. Mitchell, Inc., 103 Hwy. 82 E., Leland, MS 38756, filed ANADA 200-414 that provides for use of Formacide-B (formalin) in a water bath for the control of certain external parasites on finfish and shrimp and for the control of certain fungi on finfish eggs. B.L. Mitchell, Inc.'s Formacide-B is approved as a generic copy of Parasite-S, sponsored by Western Chemical, Inc., under NADA 140-989. The ANADA is approved as of July 17, 2007, and the regulations are amended in § 529.1030 to reflect the approval.
In addition, B.L. Mitchell, Inc., has not been previously listed in the animal drug regulations as a sponsor of an approved application. Accordingly, 21 CFR 510.600(c) is being amended to add entries for this firm.
In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Division of Dockets Management (HFA-305), Food and Drug Start Printed Page 45158Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33(a)(1) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.Start List of Subjects
List of Subjects
- Administrative practice and procedure
- Animal drugs
- Reporting and recordkeeping requirements
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine,End Amendment Part Start Part
PART 510—NEW ANIMAL DRUGSEnd Part Start Amendment Part
1. The authority citation forEnd Amendment Part Start Amendment Part
2. In § 510.600, in the table in paragraph (c)(1) alphabetically add a new entry for “B.L. Mitchell, Inc.”; and in the table in paragraph (c)(2) numerically add a new entry for “067188” to read as follows:End Amendment Part
(c) * * *
(1) * * *
|Firm name and address||Drug labeler code|
|* * * * *|
|B.L. Mitchell, Inc., 103 Hwy. 82 E., Leland, MS 38756||067188|
|* * * * *|
(2) * * *
|Drug labeler code||Firm name and address|
|* * * * *|
|067188||B.L. Mitchell, Inc., 103 Hwy. 82 E., Leland, MS 38756|
|* * * * *|
PART 529—CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGSEnd Part Start Amendment Part
3. The authority citation forEnd Amendment Part
4. In paragraph (b)(1) of § 529.1030, remove “Nos. 049968 and 050378” and add in its place “Nos. 049968, 050378, and 067188”.End Amendment Part Start Signature
Dated: August 1, 2007.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. E7-15763 Filed 8-10-07; 8:45 am]
BILLING CODE 4160-01-S